FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1144-1146 October 7, 1999 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In the past year, several studies of mice with genetically manipulated Smad genes have caught the attention of cancer researchers. Smad is a family of at least nine genes, each bearing an identifying number (e.g., Smad1, Smad2, and Smad9), and each encoding a protein involved in mediating cellular responses to transforming growth factor ß (TGF-ß) and related polypeptides. The prototype for this family of ligands was named "transforming growth factor" because it was initially identified as a serum component that stimulated neoplastic-like behavior in fibroblasts. Now we know that it has important roles in the life and death of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kelly, D. J., Zhang, Y., Connelly, K., Cox, A. J., Martin, J., Krum, H., Gilbert, R. E. (2007). Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 293: H2860-H2869 [Abstract] [Full Text]  
• Hansel, D. E., Rahman, A., Hidalgo, M., Thuluvath, P. J., Lillemoe, K. D., Shulick, R., Ku, J.-L., Park, J.-G., Miyazaki, K., Ashfaq, R., Wistuba, I. I., Varma, R., Hawthorne, L., Geradts, J., Argani, P., Maitra, A. (2003). Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression Technology. Am. J. Pathol. 163: 217-229 [Abstract] [Full Text]  
• Li, X., Schwarz, E. M., Zuscik, M. J., Rosier, R. N., Ionescu, A. M., Puzas, J. E., Drissi, H., Sheu, T.-J., O'Keefe, R. J. (2003). Retinoic Acid Stimulates Chondrocyte Differentiation and Enhances Bone Morphogenetic Protein Effects through Induction of Smad1 and Smad5. Endocrinology 144: 2514-2523 [Abstract] [Full Text]  
• Ramachandra, M., Atencio, I., Rahman, A., Vaillancourt, M., Zou, A., Avanzini, J., Wills, K., Bookstein, R., Shabram, P. (2002). Restoration of Transforming Growth Factor {beta} Signaling by Functional Expression of Smad4 Induces Anoikis. Cancer Res. 62: 6045-6051 [Abstract] [Full Text]  
• Sterner-Kock, A., Thorey, I. S., Koli, K., Wempe, F., Otte, J., Bangsow, T., Kuhlmeier, K., Kirchner, T., Jin, S., Keski-Oja, J., von Melchner, H. (2002). Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev. 16: 2264-2273 [Abstract] [Full Text]  
• Bollard, C. M., Rossig, C., Calonge, M. J., Huls, M. H., Wagner, H.-J., Massague, J., Brenner, M. K., Heslop, H. E., Rooney, C. M. (2002). Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity. Blood 99: 3179-3187 [Abstract] [Full Text]  
• Newman, J. H., Wheeler, L., Lane, K. B., Loyd, E., Gaddipati, R., Phillips, J. A. III, Loyd, J. E. (2001). Mutation in the Gene for Bone Morphogenetic Protein Receptor II as a Cause of Primary Pulmonary Hypertension in a Large Kindred. NEJM 345: 319-324 [Abstract] [Full Text]  
• Galiè, N., Torbicki, A. (2001). GENERAL CARDIOLOGY: Pulmonary arterial hypertension: new ideas and perspectives. Heart 85: 475-480 [Full Text]  
• Reeves, W. B., Andreoli, T. E. (2000). Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc. Natl. Acad. Sci. USA 97: 7667-7669 [Full Text]